Journal

Platelet-rich plasma for tendinitis: clinical indications

Platelet-rich plasma for tendinitis has described indications and clear limits. We explain what the evidence says, how the decision is made, and what the process involves.

Longevia MedicalNovember 08, 2026Leer en español

Platelet-rich plasma for tendinitis: what the evidence says and what it does not

The use of platelet-rich plasma for tendinitis is one of the most frequently requested regenerative interventions among people living with persistent tendon pain. The reason is understandable: tendons have limited circulation, and when the repair response stalls, the body cannot always resolve the injury on its own. Platelet-rich plasma aims to supply growth factors that the affected area is no longer producing in sufficient quantity.

What the evidence describes most consistently is its use in chronic tendinopathies, tendons that have been in a degenerative process for an extended period without resolution. That is not the same as saying it works for any tendon injury, at any stage, or without prior imaging assessment. The indication matters as much as the technique.

How platelet-rich plasma works in tendons

Platelet-rich plasma is obtained from a blood sample drawn from the patient. It is processed to concentrate the platelets, which upon activation release proteins involved in tissue repair. The application is generally performed through an image-guided injection directed at the area of greatest tendon compromise.

The mechanism of action in tendon tissue seeks to reactivate a repair process that has become chronic. A damaged tendon is not always inflamed in the classical sense: it is frequently in a state of degeneration without active inflammation, a condition known as tendinosis. In that context, the growth factors present in the plasma can provide a signal the tissue needs to reorganize itself.

What remains under investigation is whether the optimal platelet concentration, the number of sessions, and the intervals between them significantly alter outcomes. No single protocol has been universally adopted; current medical practice applies clinical judgment on a case-by-case basis.

The indication is not the diagnosis alone: it is the diagnosis plus the stage of the injury, plus the response of each individual tissue. Without that reading, no intervention has a point of departure.

Platelet-rich plasma for tendons: the described indications

The tendinopathies most consistently described in the literature are those of the patellar tendon, the Achilles tendon, and the rotator cuff tendon in the shoulder. In these cases, the use of platelet-rich plasma for tendons is considered when the tissue shows degenerative changes without complete rupture and when conservative treatment, including physical rehabilitation, has not resolved the condition.

  • Rotator cuff tendinopathy: partial tears with degenerative changes on imaging; the shoulder is one of the joints with the greatest body of described use.
  • Achilles tendinosis: degeneration of the mid-portion of the tendon, without macroscopic rupture.
  • Patellar tendinosis: also known as jumper's knee; frequently documented in individuals with sustained physical activity.
  • Lateral epicondylitis: tennis elbow with chronic progression; one of the indications with the largest number of publications in this area.

In all of these cases, the indication begins with a complete physical examination combined with imaging, either musculoskeletal ultrasound or magnetic resonance imaging. Imaging is not a formality: it determines whether there is a partial tear, pure tendinosis, or a complete rupture that would redirect the treatment path entirely.

Platelet-rich plasma in the shoulder: real indications and real limits

The use of platelet-rich plasma in the shoulder has an indication described primarily for partial rotator cuff tears and supraspinatus tendinopathy. The rationale is the same: tissue with insufficient repair capacity, without complete discontinuity, in a patient who has already undergone rehabilitation without resolution.

The limit is clear and allows no ambiguity: a complete rotator cuff rupture is not an indication for platelet-rich plasma as the sole intervention. In that scenario, surgical assessment is the appropriate path. Attempting to resolve a complete rupture with plasma is not only unsupported by evidence, it can delay a necessary intervention.

A completely ruptured tendon does not regenerate with growth factors. Imaging defines the path, not the intensity of the pain.

There is another limit that is frequently underestimated: the overall condition of the connective tissue. In individuals with conditions affecting collagen quality or with uncontrolled systemic conditions, the response to plasma may differ. That is why the assessment is not limited to the tendon: it includes the patient's metabolic and general health context.

How the indication is decided: imaging, examination, and context

The decision to indicate platelet-rich plasma for tendinitis does not begin with a symptom or an age. It begins with the integration of three sources: the physical examination, the imaging study, and the history of prior treatments. Without that full picture, any indication is incomplete.

  • Physical examination: identifies the area of greatest pain, range of motion, tendon function, and any signs of rupture that imaging must confirm.
  • Imaging: musculoskeletal ultrasound or magnetic resonance imaging to classify the injury. Ultrasound offers the advantage of dynamic assessment; MRI provides greater structural detail in complex injuries.
  • Treatment history: duration of symptoms, type of rehabilitation completed, and response to prior treatments. Plasma is not a first-line resource in acute tendinopathies.

This process is consolidated in the clinical assessment. During that assessment, the team determines whether there is an indication, which protocol applies, how many sessions the plan includes, and how follow-up is structured. The plan is delivered in writing and serves as the reference document throughout the entire process.

Rehabilitation and platelet-rich plasma: a path that does not separate

Rehabilitation is not an optional complement to plasma: it is part of the protocol. Without progressive exercise and controlled loading of the tendon, the biological signal provided by the platelets does not translate into functional tissue reorganization. Guided movement is part of the mechanism.

In general medical practice, rehabilitation is scheduled in coordination with the application. The physical therapist or rehabilitation physician works with the tendon's timeline, not the patient's. Advancing load before the tissue is prepared can reverse the progress achieved.

When the patient lives outside the city where treatment was received, follow-up continues remotely. Medical supervision does not end with the session: it includes reading the tissue's response, adjusting the rehabilitation protocol, and deciding whether an additional session is needed or whether the plan is complete.

The tendon responds to load. Platelet-rich plasma creates conditions; rehabilitation converts those conditions into function.

What remains under investigation and what does not apply

It is useful to clearly separate three categories. First, what is accepted: the use of platelet-rich plasma in chronic tendinopathies without complete rupture, particularly in the shoulder, elbow, knee, and Achilles, is a recognized medical practice with description in the clinical literature.

Second, what remains under study: optimal dosing, ideal platelet concentration, the precise number of sessions, combination with other regenerative interventions, and patient selection based on biological markers. These variables do not yet have universal consensus.

Third, what does not apply: complete tendon ruptures as the sole indication, injuries with active infection at the site, and systemic conditions that the physician must assess before any invasive procedure. There is also no evidence supporting its use in acute injuries as a first-line approach.

flowchart TD
    A["Persistent tendon pain"] --> B["Physical examination"]
    B --> C["Imaging study"]
    C --> D{"Type of injury?"}
    D -->|"Tendinopathy or partial tear"| E["Assessment for PRP indication"]
    D -->|"Complete rupture"| F["Surgical assessment"]
    E --> G["Prior or concurrent rehabilitation"]
    G --> H["Session protocol with follow-up"]
    H --> I["Re-evaluation with imaging if indicated"]

Platelet-rich plasma for tendinitis: how long the process takes and how response is measured

One of the most frequent questions is how long it takes for platelet-rich plasma to take effect. The honest answer is that tendon is a slowly remodeling tissue. The biological response is not immediate and is not measured by the disappearance of pain in the first few days: it is measured by the progression of function, the load tolerated, and, when applicable, changes observed on a follow-up imaging study.

The number of sessions a protocol includes varies according to the diagnosis, the stage of the injury, and the individual response. There is no fixed number that applies to every case. The physician defines the protocol during the assessment and adjusts it throughout follow-up.

Frequently asked questions about platelet-rich plasma for tendinitis

Does platelet-rich plasma work for any type of tendinitis?

No. Its described indication is for chronic tendinopathies without complete tendon rupture. An acute injury or a full rupture requires a different path. Imaging and physical examination determine whether there is an indication.

How many platelet-rich plasma sessions does a tendon need?

The number varies according to the diagnosis, the stage of the injury, and the individual response. There is no fixed number valid for every case. The protocol is defined during the assessment and reviewed throughout follow-up.

Can platelet-rich plasma in the shoulder replace surgery?

Not in every case. A complete rotator cuff rupture requires surgical assessment. Plasma has an indication in partial tears with degenerative changes. Attempting to substitute a necessary surgery with plasma can delay the appropriate care.

What should I do if I experience intense pain or skin color changes after a plasma injection?

Intense immediate pain, skin that turns white or purple, or any new neurological symptom after an injection requires emergency care right away. This is not a situation to handle with a message to the clinic.

Can platelet-rich plasma be combined with physical rehabilitation?

Yes, and in most protocols rehabilitation is part of the plan, not an optional complement. Progressive exercise with controlled loading is part of the response mechanism in a tendon treated with plasma.

If you are researching this topic at home before making a decision, Mayo Clinic and MedlinePlus offer general information on tendon injuries and treatment options that may be useful as a reference.

At Longevia Medical, located in Puerto Cancún, care begins with an assessment, in person or remote. The plan is individual, delivered in writing, and follow-up continues when you return home. If you have a tendinopathy diagnosis or an unresolved shoulder injury, a private consultation or a remote assessment is the starting point for determining whether this path applies to your case.

Begin privately

Tell us what you want to protect.

This first conversation is for orientation, not diagnosis. A coordinator will identify the right clinical pathway and explain the secure next step.

Request a private consultation↗

Book a private consultation

Tell us what you want to protect.

Choose a preferred date and time. A coordinator confirms your appointment by WhatsApp or email and explains the secure next step. This first conversation is for orientation, not diagnosis.

Do not include medical records or sensitive health information here.
Thank you. We received your request. A coordinator will confirm your appointment by WhatsApp or email.